JP MORGAN/CALL/BOSTON SCIENTIFIC/75/0.1/17.01.25 | Market Closed - Börse Stuttgart 03:20:58 2024-06-14 am EDT | ||
| 1.01 EUR | -4.72% |
|
| Current month | +7.45% | ||
| 1 month | +23.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 1.01 | -4.72% |
| 24-06-13 | 1.06 | -0.93% |
| 24-06-12 | 1.07 | -0.93% |
| 24-06-11 | 1.08 | +2.86% |
| 24-06-10 | 1.05 | +8.25% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 03:20 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK056E |
| ISIN | DE000JK056E2 |
| Date issued | 2024-02-01 |
| Strike | 75 $ |
| Maturity | 2025-01-17 (215 Days) |
| Parity | 10 : 1 |
| Emission price | 0.19 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.08 € |
|---|---|
| Lowest since issue | 0.48 € |
| Spread | 0.04 € |
| Spread % | 3.77% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.76
USD
Average target price
82.26
USD
Spread / Average Target
+7.16%
- Stock Market
- Warrants
- Warrant
